Please select the option that best describes you:

How are you modifying your current sarcoma-directed therapy in the setting of the COVID-19 pandemic?   

For example, would you consider switching to an outpatient regimen in lieu of AIM for metastatic soft tissue sarcoma?



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more